文献速递衰弱、肌少症与跌倒认知障碍与谵妄多重用药

痴呆老年人衰弱患病率的系统综述

The Prevalence of Frailty Among Older Adults Living With Dementia: A Systematic Review.
PubMed 文献 · J Am Med Dir Assoc · 2022-03-10

急性照护机构中衰弱患病率为50.8%至91.8%,社区居住者为24.3%至98.9%。衰弱组用药总数高于非衰弱组。

要点

  • 痴呆老年人衰弱患病率范围宽,急性照护为50.8%–91.8%,社区为24.3%–98.9%。
  • 衰弱状态与用药数量相关,衰弱者用药总数高于非衰弱者。
  • 现有研究未系统记录痴呆患者的衰弱状态及其对用药的影响。

核心结论

  • 当前数据显示痴呆个体中衰弱患病率范围较宽。
  • 未来研究应系统记录痴呆老年人的衰弱状况及其对用药的影响。

研究设计与样本

  • 系统综述,检索Embase、Medline、International Pharmaceutical Abstracts、APA PsycInfo、CINAHL、Scopus和Web of Science,从建库至2020年8月20日。
  • 其中7项研究在急性照护机构进行,9项在社区居住成人中进行;5项仅招募痴呆患者,11项在包含痴呆诊断的老年人群中开展。
  • 两名评价者独立筛选文献并使用Newcastle-Ottawa量表进行质量评价。

主要发现

  • 急性照护机构中衰弱患病率为50.8%至91.8%。
  • 社区居住环境中衰弱患病率为24.3%至98.9%。
  • 3项研究记录了按衰弱状态(而非痴呆状态)的用药情况。
  • 衰弱组用药总数范围为7.0±4.0(SD)至12.0±9.0(SD),非衰弱组为6.1±3.1(SD)至10.4±3.8(SD)。

临床怎么用

  • 在痴呆老年人中应关注衰弱评估,因患病率范围宽且可能影响用药管理。
  • 临床用药管理可考虑衰弱状态,衰弱者用药总数较高。

局限性

  • 纳入研究异质性大,衰弱患病率范围宽。
  • 仅3项研究按衰弱状态记录用药,且未按痴呆状态分析。
  • 未来需系统记录痴呆患者的衰弱状态及其对用药的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the prevalence of frailty in older adults living with dementia and explore the differences in medication use according to frailty status. DESIGN: Systematic review of published literature from inception to August 20, 2020. SETTING AND PARTICIPANTS: Adults age ≥65 years living with dementia in acute-care, community and residential care settings. METHODS: A systematic search was performed in Embase, Medline, International Pharmaceutical Abstracts, APA PscyInfo, CINAHL, Scopus, and Web of Science. Two reviewers independently screened records and conducted quality assessment using the Newcastle-Ottawa Scale. RESULTS: Sixteen articles met the inclusion criteria, with 7 studies conducted in acute care setting and 9 studies in community-dwelling adults. Five studies recruited people with dementia exclusively, and 11 studies were conducted in older populations that included individuals with dementia diagnosis. Among studies conducted in acute care setting, the prevalence of frailty ranged from 50.8% to 91.8% compared with studies in community-dwelling setting, which reported a prevalence of 24.3% to 98.9%. With respect to medication exposure, 3 studies documented medication use according to frailty status but not dementia status. Higher medications use, measured as total number of medications was reported in frail [7.0 ± 4.0 (SD) -12.0 ± 9.0 (SD)] compared with nonfrail participants [6.1 ± 3.1(SD) -10.4 ± 3.8 (SD)]. CONCLUSIONS AND IMPLICATIONS: Current data suggests a wide range of frailty prevalence in individuals with dementia. Future studies should systematically document frailty in adults living with dementia and its impact on medication use.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Koria LG, Sawan MJ, Redston MR, et al. The Prevalence of Frailty Among Older Adults Living With Dementia: A Systematic Review. J Am Med Dir Assoc. 2022. PMID: 35283085. doi:10.1016/j.jamda.2022.01.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。